Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2014, Vol. 41 Issue (1): 48-51    DOI: 10.12891/ceog15662014
Original Research Previous articles | Next articles
Age of menarche as a risk factor for gynecological cancer in Iranian women and review of the literature
E. Barooti1, M. Karimi-Zarchi2, *(), N. Sadeghi3, S. Teimoori4, Z. Chiti5
1Functional Gynecology, Teleghani Hospital, Tehran
2Gynecology Oncology Department, Shahid Sadoughi University of Medical Science, Yazd
3Department of Obstetrics and Gynecology, Tehran University of Medical Science, Tehran
4Department of Internal Medicine, Azad University of Medical Science, Yazd Branch, Yazd
5Azad University of Medical Science, Yazd Branch, Shahid Sadoughi University of Medical Science, Yazd (Iran)
Download:  PDF(59KB)  ( 7 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Background: This study analyzed the age of menarche in different regions of Iran with a review of previous studies and examined the changes of menarche age over the past years. Materials and Methods: A descriptive and cross-sectional study which was conducted in 11 different provinces of Iran with a sample size of 26,831. The year of birth and age of menarche in the population obtained through health records which were available in the health centers collected and also questioning the subjects under investigation. Results: The highest average age of 14.6 years obtained from Kermanshah province and the lowest was from Kerman with 12.98 years. The lowest average was observed with age group under 30 (13.22) and the highest age of menarche (13.53) belonged to the 30 to 40 year age group. The average age of menarche in this study was 13.24 years. Discussion: A declining trend of about two to four months for each ten years has been observed in girls born in 1920s to 1940s and then an upward trend of about nine months for ten years in subjects born in 1950s and 1960s. The stressful condition of war and poor economic and social conditions of Iranian people can justify this upward leap. However in women under 30 years of age, the menarche age showed a rapid declining trend to 13.22 years. Conclusion: Obtaining accurate information and knowing all the factors affecting this issue can be very useful in planning the public health in women and health educational programs.
Key words:  Age of menarche      Risk factors      Gynecological cancer     
Published:  10 February 2014     
*Corresponding Author(s):  M. KARIMI-ZARCHI     E-mail:  drkarimi2001@yahoo.com

Cite this article: 

E. Barooti, M. Karimi-Zarchi, N. Sadeghi, S. Teimoori, Z. Chiti. Age of menarche as a risk factor for gynecological cancer in Iranian women and review of the literature. Clinical and Experimental Obstetrics & Gynecology, 2014, 41(1): 48-51.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog15662014     OR     https://ceog.imrpress.com/EN/Y2014/V41/I1/48

[1] S.H. Ryu, B.S. Jang, J.H. Lee, H.J. Jeong, G.C. Kim, Y.J. Sim. Comparison of bilateral lymphedema and unilateral lymphedema in lower extremities after gynecologic cancer surgery[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(6): 829-834.
[2] J. Ogawa, S. Suzuki. Risk factors of self-interruption of medications for mental disorders in pregnancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 576-578.
[3] Li Li Zhang, Hua Shu, Shuai Zhang, Tian Tian Wang, Lan Lan Zhang. Pregnancy outcomes and risk factors in pregnant women with systemic lupus erythematosus[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 189-193.
[4] T. T. Kitova, B. D. Kitov, E. H. Uchikova, N. T. Ahmad. Maternal age - a risk factor for congenital hydrocephalus[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 257-261.
[5] S.M.S. Fernandes, J.C.L. Ribalta, N.M.G. Speck, Y. Yamamura. Treatment of uterine cervical ectopy with acupuncture and analysis of risk factors in the metaplastic process[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(4): 601-605.
[6] M. Li, L. Riming, W. Zhe, W. Hong, H. Xiaofei, C. Lina, Z. Zhengfang, W. Xuebo, W. Ning, S. Chengming, H. Qing-qing, L. Hailiang, W. Hui. Non-invasive prenatal screening for chromosome 21, 18, and 13 aneuploidies in a mixed risk factors pregnancy population[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(4): 523-528.
[7] F.Q. Ma, G.Y. Zhang, J.B. Gao, C. Fang, Y. Bo, G.Y. Huang, A.H. Zhang. Clinical screening method and risk factors’ analysis of congenital cardiovascular defects: a case control study from a Chinese local region[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(4): 515-520.
[8] G. Özakşit, A. Tokmak, H. Kalkan, E. Sarıkaya. Is there an association between serum vitamin D levels and endometrial polyps?[J]. Clinical and Experimental Obstetrics & Gynecology, 2016, 43(4): 539-543.
[9] Y. Yuan, W. Zhou, X. Rong, W.N. Lu, Z. Zhang. Incidence and factors associated with nosocomial infections in a neonatal intensive care unit (NICU) of an urban children’s hospital in China[J]. Clinical and Experimental Obstetrics & Gynecology, 2015, 42(5): 619-628.
[10] G. Carta, A. D’Alfonso, V. Parisse, A. Di Fonso, M. Casacchia, F. Patacchiola. How does early cognitive behavioural therapy reduce postpartum depression?[J]. Clinical and Experimental Obstetrics & Gynecology, 2015, 42(1): 49-52.
[11] E. Diaz Mohedo, J. Warnberg, F.J. Baron Lopez, S. Mera Velasco, A. Cabello Burgos. Chronic pelvic pain in Spanish women: prevalence and associated risk factors. A cross-sectional study[J]. Clinical and Experimental Obstetrics & Gynecology, 2014, 41(3): 243-248.
[12] A.B. Hooker, B.R. van Moorst, E.P. van Haarst, N.A.M. van Ootegehem, D.K.E. van Dijken, M.H.B. Heres. Chronic pelvic pain: evaluation of the epidemiology, baseline demographics, and clinical variables via a prospective and multidisciplinary approach[J]. Clinical and Experimental Obstetrics & Gynecology, 2013, 40(4): 492-498.
[13] L. Yang, W. Zhang, L. Zhang, S. Zhang, Y. Yang, Q. Wang, J. Shao, G. Chen, Y. Wang. Gestational hypertension risk evaluation based on epidemiological, biochemical, and hemodynamic factors[J]. Clinical and Experimental Obstetrics & Gynecology, 2013, 40(1): 61-65.
[14] G. Paradisi, M. Bracaglia, F. Basile, S. D’Ippolito, F. Di Nicuolo, F. Ianniello, L. Quagliozzi, L. Donati, A. Labianca, C. Di Cesare, M. Viggiano, A. Biaggi, C. De Waure, F. Andreotti, N. Di Simone, A. Caruso. Effect of pravastatin on endothelial function and endothelial progenitor cells in healthy postmenopausal women[J]. Clinical and Experimental Obstetrics & Gynecology, 2012, 39(2): 153-159.
[15] J. Patumanond, C. Tawichasri, S. Khunpradit. Clinical risk score to recognize macrosomia at the time of delivery[J]. Clinical and Experimental Obstetrics & Gynecology, 2012, 39(2): 195-199.
No Suggested Reading articles found!